Dyadic International Inc (DYAI)
1.20
+0.08
(+7.14%)
USD |
NASDAQ |
Nov 14, 12:42
Dyadic International Shareholders Equity (Quarterly): 3.168M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 3.168M |
| March 31, 2024 | 4.516M |
| December 31, 2023 | 5.879M |
| September 30, 2023 | 7.652M |
| June 30, 2023 | 8.986M |
| March 31, 2023 | 10.80M |
| December 31, 2022 | 11.09M |
| September 30, 2022 | 12.61M |
| June 30, 2022 | 13.56M |
| March 31, 2022 | 16.39M |
| December 31, 2021 | 18.39M |
| September 30, 2021 | 21.90M |
| June 30, 2021 | 23.16M |
| March 31, 2021 | 25.69M |
| December 31, 2020 | 28.45M |
| September 30, 2020 | 29.99M |
| June 30, 2020 | 32.09M |
| March 31, 2020 | 34.25M |
| December 31, 2019 | 35.86M |
| September 30, 2019 | 37.24M |
| June 30, 2019 | 38.62M |
| Date | Value |
|---|---|
| March 31, 2019 | 40.59M |
| December 31, 2018 | 42.45M |
| September 30, 2018 | 42.91M |
| June 30, 2018 | 46.30M |
| March 31, 2018 | 47.83M |
| December 31, 2017 | 49.98M |
| September 30, 2017 | 51.79M |
| June 30, 2017 | 53.23M |
| March 31, 2017 | 54.44M |
| December 31, 2016 | 57.69M |
| September 30, 2016 | 63.25M |
| June 30, 2016 | 68.03M |
| March 31, 2016 | 69.21M |
| December 31, 2015 | 73.79M |
| September 30, 2015 | -0.6302M |
| December 31, 2014 | -2.265M |
| March 31, 2014 | 1.172M |
| December 31, 2013 | 2.568M |
| September 30, 2013 | 2.982M |
| June 30, 2013 | 4.405M |
| March 31, 2013 | 0.7612M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
3.168M
Minimum
Jun 2024
35.86M
Maximum
Dec 2019
18.13M
Average
16.39M
Median
Mar 2022
Shareholders Equity (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 6.102M |
| Perspective Therapeutics Inc | 341.00M |
| Protalix BioTherapeutics Inc | 28.58M |
| Electromed Inc | 44.54M |
| Armata Pharmaceuticals Inc | -46.10M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 10.63M |
| Total Liabilities (Quarterly) | 7.462M |
| Debt to Equity Ratio | 1.721 |
| Current Ratio | 5.390 |
| Net Debt Paydown Yield | -2.50% |